1. Males and females ≥ 18 years old. 
2. Clinical diagnosis of type 1 diabetes for at least one year. 
3. The subject will have been on insulin pump therapy for at least 3 months and currently using a fast actin insulin analog (Lispro, Aspart or Guilisine). 
4. Last (less than 3 months) HbA1c ≤ 10%. 
5. Currently using carbohydrate counting as the meal insulin dose strategy. 

NCT02416765_inc_T6
Person
Males
NCT02416765_inc_T8
Person
females
NCT02416765_inc_T9
Person
old
NCT02416765_inc_T10
Value
≥ 18 years old
NCT02416765_inc_T11
Condition
type 1 diabetes
NCT02416765_inc_T12
Temporal
for at least one year
NCT02416765_inc_T13
Procedure
insulin pump therapy
NCT02416765_inc_T14
Temporal
for at least 3 months
NCT02416765_inc_T15
Temporal
currently
NCT02416765_inc_T16
Drug
fast actin insulin analog
NCT02416765_inc_T17
Drug
Lispro
NCT02416765_inc_T18
Drug
Aspart
NCT02416765_inc_T19
Drug
Guilisine
NCT02416765_inc_T20
Scope
Lispro, Aspart or Guilisine
NCT02416765_inc_T21
Measurement
HbA1c
NCT02416765_inc_T22
Value
≤ 10%
NCT02416765_inc_T23
Temporal
Last (less than 3 months)
NCT02416765_inc_T24
Procedure
carbohydrate counting
NCT02416765_inc_T25
Procedure
meal insulin dose strategy
NCT02416765_inc_T26
Temporal
Currently